Teamwork, New Technology Now Helping Doctors 'Gang-Tackle' Skin Cancer Threat

August 13, 1998

CHAPEL HILL - Like successful defensive players on a football field, physicians at the University of North Carolina at Chapel Hill are gang-tackling a tough opponent - skin cancer.

And, like aerial reconnaissance experts studying enemy ground movements, they also are using new digital photography technology to track changes in skin so that moles don't turn into a mountain of problems for patients.

"This is a UNC School of Medicine-wide initiative that involves dermatology, surgical oncology, medical oncology, pathology and other groups," said Dr. Robert A. Briggaman, chairman of dermatology. "It's people with different forms of expertise putting their heads together to identify melanoma as early as possible and manage it in the most appropriate fashion.

"We collaborate more than ever because this cancer is a very complicated disease that is probably the most rapidly increasing form of cancer humans face. Each member of our team at our new multidisciplinary melanoma clinic does what he or she does best."

Sometimes, treating melanoma is as simple as cutting away a small mole or other lesion that has become cancerous, Briggaman said. Cases not caught as early may involve tracking cancer cells from the original tumor to lymph nodes with weak radioactive tracers and a hand-held Geiger counter. Surgery, chemotherapy, immunotherapy or radiation therapy may follow.

Excessive exposure to the sun through working out outdoors or sunbathing can cause melanoma or the other two major forms of skin cancer -- basal cell and squamous cell carcinoma - which usually are not as deadly. Clearly, some melanomas have nothing to do with sunlight, however, and may have more to do with genetic inheritance or environmental exposures, he said.

Others involved in the new pigment lesion clinic - and members of the UNC Lineberger Comprehensive Cancer Center -- include Drs. Lisa May of dermatology, Benjamin F. Calvo and Michael Zenn of surgery and Mark L. Graham II of medical oncology. To learn whether tumors have spread there, Calvo biopsies sentinel nodes -- structures draining lymph from particular parts of the body. Graham treats patients with more extensive disease with interferon and other promising agents.

"With help from our School of Medicine photography department, we take a series of images with a digital camera and store those images via computer on compact discs for use when patients return for future appointments," May said. "One of the hardest things for dermatologists is to know is whether a lesion is new since the last visit or whether it has changed in some significant way.

"This technology, which is being used like this in only a few medical centers in the United States, also helps calm anxiety in patients who may have hundreds of moles or who have a family or personal history of melanoma," she said.

Technicians store 36 different pictures of each patient covering most of the body, and the resulting CD, which will last at least several decades, becomes part of patients' permanent medical record, May said. Unlike with conventional photographs, diagnosticians can zoom in on any given area to examine it more closely.

Pigmented lesions are chiefly moles, but also include freckles, sun and age spots and keratoses, she said.

"Criteria for suspecting skin cancer have been called the 'ABCD' of melanoma,'" May said. "'A' stands for asymmetry, meaning half a mole, for example, does not look like the other half. 'B' stands for a border that is notched or that has pigment extending beyond it."

"C" represents color; doctors become suspicious of variations of color and particularly dark browns, blacks, reds and whites. "D" is diameter, and any lesions larger in diameter than a pencil eraser also raise concern.

"All of those warrant having a dermatologist evaluate the lesion," she said. "The other big thing not part of the ABCD idea is change. If a mole is itching or bleeding, growing darker, raising up or just growing, we want to take a look at it."

People need to be not worried, but should be vigilant about melanoma, May said. In 1935, the lifetime risk of the illness was one in 1,500, while by 1960, it was one in 600.

"The lifetime risk is projected to be one in 75 by the year 2000, and it already is the most common cancer among women ages 25 to 29."

Note: Briggaman and May can be reached at (919) 966-0785.

University of North Carolina at Chapel Hill

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to